Form D · Other Health Care
BioDerm Holdings, LP
Denver, CO · CIK 0001840003
Offering snapshot reported Feb 6, 2023 · SEC filing
- Reported sold
- $85.4M Offering amount: $85.4M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2023 | Initial | $85,357,000 | No comparison | 32 | SEC filing |
| Jan 13, 2021 | Initial | $45,500,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-472747
Source: Form D, filed Feb 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Blazejewski | Director |
| Gary Damkoehler | Director |
| Stew Fisher | Director, Executive |
| Madhura Palkar | Director |
| Arion Robbins | Director |
| Bruce Rogers | Director, Executive |
| James Royston | Director, Executive |
| Jay Royston | Director, Executive |
| Gaet Tyranski | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Mountaingate Capital Management, L.P 1225 17th Street, Suite 2575
Denver, CO, 80202
Denver, CO, 80202